Is a prescription medicine used to treat adults with chronic myeloid leukemia.
Read MoreIs a newly approved injectable medication used for moderate-to-severe systemic lupus erythematosus (anifrolumab or anifrolumab-fnia).
Read MoreIs indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer.
Read MoreTukysa (tucatinib) is a tyrosine kinase inhibitor, treats certain advanced-stage HER2-positive breast cancers
Read MoreAbraxane® is used to treat breast cancer, non-small cell lung cancer and cancer of the pancreas.
Read MoreIDHIFA® is a prescription medicine used to treat people with acute myeloid leukemia.
Read MoreKIMMTRAK is an anti-cancer medication used to treat uveal melanoma.
Read MoreVabysmo is a prescription medicine used to treat the symptoms of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema.
Read MoreENJAYMO (sutimlimab-jome) is indicated to decrease the need for red blood cell (RBC) transfusion due to hemolysis in adults with cold agglutinin disease.
Read MoreTIBSOVO® is a prescription medicine used to treat adults with bile duct cancer.
Read MoreBALVERSA® is a prescription medicine used to treat adults with bladder cancer.
Read MoreWELIREG is indicated for the treatment of adult patients with von Hippel-Lindau (VHL) disease.
Read MoreTIVDAK is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer.
Read MoreLénalidomide Sandoz is a prescription medicine, used to treat adults with multiple myeloma.
Read MorePIQRAY is indicated for patients with HR+/HER2- advanced or metastatic breast cancer…
Read MoreTAZVERIK is a prescription medicine used to treat Adults with follicular lymphoma.
Read MoreStelara is indicated for the treatment of adult patients with moderately to severely active Crohn's disease.
Read MoreENHERTU is a HER2-directed antibody and topoisomerase inhibitor conjugate indicated for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer.
Read MoreIs approved to treat adults diagnosed with metastatic triple-negative breast cancer who have received at least two previous treatments for metastatic disease.
Read MoreActemra (tocilizumab) 400mg / 20ml is indicated for the treatment of active systemic arthritis.
Read More